IRVING, Texas – McKesson Corp. announced the launch of Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities. Led by McKesson’s Global Impact Organization and Community Pharmacy & Health, Project Oasis seeks to identify and address pharmacy deserts, particularly in urban areas where residents face significant challenges in accessing essential pharmacy
IRVING, Texas — McKesson has launched Foster & Thrive, a curated private brand of over-the-counter (O-T-C) health and wellness products. Launching Foster & Thrive unifies the company’s private brand portfolio—consolidating Health Mart and Sunmark branded O-T-C products—to offer expanded availability through increased production volumes and efficiencies that will help meet evolving patient needs and growing
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) and McKesson Corp. reached an agreement on Tuesday for WBA to acquire the remaining 30% share of their GEHE Pharma Handel (GEHE) and Alliance Healthcare Deutschland (AHD) joint venture. Following this transaction, WBA will become the 100% owner of the combined GEHE and Alliance Healthcare businesses in Germany.
DEERFIELD, Ill. – Walgreens Boots Alliance (WBA) and McKesson Corp. announced on Monday the completion of their previously announced agreement to create a joint venture combining their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland (AHD) and GEHE Pharma Handel (GEHE). WBA holds a 70% controlling equity interest in the joint venture and McKesson
IRVING, Texas — McKesson Corp. has appointed Rebecca McKillican as chief executive officer, McKesson Canada effective immediately. McKillican succeeds Domenic Pilla, who announced his plans to retire from the company in late 2019. Rebecca McKillican As CEO, McKillican is responsible for leading McKesson’s portfolio of businesses in Canada including pharmaceutical distribution operations, McKesson Canada Specialty
This installment of the Chain Drug Review/MMR Video Forum series features insights on McKesson’s network of franchised pharmacies. Health Mart president Nimesh Jhaveri and franchisee Ghada Zuhair Abu Kuwaik, owner and chief pharmacist at CureMed Pharmacy in Clifton, N.J., discuss the network’s response to COVID-19 and the future role of community pharmacy.
IRVING, Texas — Veteran McKesson leader, Brian Tyler, has become the company’s new chief executive officer Monday, succeeding John Hammergren. Hammergren has served as the company’s top executive since 1999. “I am incredibly humbled and grateful for the opportunity to lead this company,” said Brian Tyler, chief executive officer, McKesson Corp. “We have a seasoned and talented
SAN FRANCISCO — McKesson Corp. announced that John Hammergren, chairman and chief executive officer, has decided to retire, effective March 31, 2019. McKesson’s board of directors has unanimously selected Brian Tyler, currently president and chief operating officer, to succeed Hammergren as CEO, effective April 1, 2019. Tyler will also remain as president. Edward Mueller, currently
SAN FRANCISCO — McKesson Corp. has named Brian Tyler as president and chief operating officer, effective August 2. He will report to John Hammergren, chairman and chief executive officer, and will become a member of the executive committee. McKesson also announced that Nick Loporcaro, president of McKesson’s U.S. Pharmaceutical and Specialty Solutions segment, has decided
SAN FRANCISCO and TORONTO — McKesson Corp. has closed its $2.1 billion (U.S.) acquisition of Canadian drug chain Rexall Health and hired Domenic Pilla as chief executive officer of McKesson Canada. Earlier this month, McKesson gained clearance from the Competition Bureau of Canada to finalize the Rexall Health acquisition, which was announced in early March.